WP
CNTA

Woodline Partners’s Centessa Pharmaceuticals CNTA Stock Holding History

Woodline Partners’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.1M Buy
859,105
+280,854
+49% +$7.18M 0.13% 213
2025
Q4 		$14.5M Buy
578,251
+470,580
+437% +$11.9M 0.06% 375
2025
Q3 		$2.61M Sell
107,671
-292,607
-73% -$5.2M 0.01% 691
2025
Q2 		$5.26M Hold
400,278
– – 0.03% 547
2025
Q1 		$5.76M Sell
400,278
-145,367
-27% -$2.38M 0.04% 469
2024
Q4 		$9.14M Buy
545,645
+29,266
+6% +$485K 0.06% 364
2024
Q3 		$8.26M Buy
516,379
+392,918
+318% +$4.81M 0.07% 330
2024
Q2 		$1.11M Buy
+123,461
New +$1.17M 0.01% 453
2024
Q1 		– Sell
-140,856
Closed -$1.12M – 554
2023
Q4 		$1.12M Sell
140,856
-69,348
-33% -$465K 0.01% 400
2023
Q3 		$1.36M Sell
210,204
-477,559
-69% -$3.27M 0.02% 425
2023
Q2 		$4.26M Sell
687,763
-48,230
-7% -$229K 0.05% 315
2023
Q1 		$2.83M Buy
735,993
+516,573
+235% +$1.89M 0.04% 377
2022
Q4 		$680K Buy
219,420
+40,852
+23% +$151K 0.01% 574
2022
Q3 		$718K Sell
178,568
-1,136,084
-86% -$5.2M 0.01% 561
2022
Q2 		$6.4M Buy
1,314,652
+432,019
+49% +$2.76M 0.1% 223
2022
Q1 		$7.92M Buy
882,633
+81,497
+10% +$743K 0.13% 195
2021
Q4 		$9.02M Sell
801,136
-81,677
-9% -$1.1M 0.13% 210
2021
Q3 		$14.7M Buy
882,813
+60,295
+7% +$1.25M 0.24% 115
2021
Q2 		$18.3M Buy
+822,518
New +$19.3M 0.34% 77

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Woodline Partners's CNTA Position: Q1 2026 in Review

Woodline Partners increased its Centessa Pharmaceuticals (CNTA) stake by 49% in Q1 2026, buying an estimated $7.18M and bringing the position to 859,105 shares worth $34.1M. The position accounts for 0.13% of the portfolio, ranked #213.

Woodline Partners first reported a position in CNTA in Q2 2021 and has held it in 19 quarters since. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • Woodline Partners held 859,105 shares of Centessa Pharmaceuticals worth $34.1M as of Q1 2026.
  • Woodline Partners bought 280,854 Centessa Pharmaceuticals shares in Q1 2026, an estimated $7.18M.
  • Centessa Pharmaceuticals made up 0.13% of Woodline Partners's portfolio in Q1 2026, its #213 holding.
  • Woodline Partners first reported a position in Centessa Pharmaceuticals in Q2 2021 and has held it in 19 quarters since.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.